Background diabetic retinopathy
MONDO:0001661An early stage of diabetic retinopathy that is characterized by retinal hemorrhage and exudate, but without proliferation of the blood vessels.
Also known as: non-proliferative diabetic retinopathy
45 clinical trials for this condition and its sub-types, 26 tagged with Background diabetic retinopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Background diabetic retinopathy
-
New eye injection aims to halt diabetic vision loss
Disease control OngoingThis study tests an experimental drug called BI 764524, given as an eye injection, in 190 adults with moderate to severe diabetic retinopathy. Participants receive different numbers of injections over a year, and doctors compare eye damage improvements against a sham procedure or…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New eye drops aim to boost blood flow in diabetic retinopathy and glaucoma
Disease control OngoingThis early study tests whether QLS-111 eye drops can improve blood flow to the back of the eye in people with non-proliferative diabetic retinopathy or certain types of glaucoma. Fourteen participants will use the drops twice daily for two weeks. The main goal is to measure chang…
Phase 2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Common heart drug may shield eyes of type 1 diabetes patients
Disease control OngoingThis study tests whether fenofibrate, a drug typically used to lower blood fats, can slow the worsening of diabetic retinopathy (eye damage) in adults with type 1 diabetes. Over 400 participants take either fenofibrate or a placebo daily for three years. The goal is to see if the…
Phase 3 • Sponsor: University of Sydney • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Cheap pill could save millions from blindness, major trial launches
Prevention OngoingThis study tests whether fenofibrate, a drug already used for high cholesterol, can prevent diabetic retinopathy from worsening in people with mild to moderate disease. About 560 adults with diabetes will take either fenofibrate or a placebo for up to 6 years. The goal is to see …
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Diabetes cataract study pulled before starting
Symptom relief CancelledThis study was designed to compare a tiny steroid insert (Dextenza) placed in the tear duct against standard steroid eye drops (prednisolone) after cataract surgery in people with diabetes. The goal was to see which better controls eye inflammation and swelling. However, the stud…
Phase 4 • Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC